Log in to search using one of your social media accounts:

 

Risk-based lung cancer screening tops USPSTF guidelines

Using individual risk-based criteria to determine eligibility for CT lung cancer...Read more on AuntMinnie.comRelated Reading: Chest doctors issue guidelines for CT lung cancer screening Canadian risk model boosts CT lung screening efficiency Smokers not picking up the CT lung screening habit Risk model fine-tunes CT lung cancer screening Fewer lung cancer patients meet CT lung screening criteria
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Conclusion: High-dose preoperative chemoradiotherapy was safe and effective. This combination should be further considered.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Radical thoracic radiotherapy is a mainstay in the treatment of non-small cell lung cancer (NSCLC); however, the effect of cardiac doses on survival is becoming increasingly important, as highlighted ... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
The anti-PD-1 antibody therapy pembrolizumab is an exciting new agent for the treatment of non-small cell lung cancer (NSCLC). Here, Martin Reck, MD, PhD, of the Lung Clinic Grosshansdorf, Grosshansdo... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
The IMpower150 trial (NCT02366143) was the first to explore chemotherapy, immunotherapy with atezolizumab and anti-angiogenic therapy with bevacizumab for non-small cell lung cancer (NSCLC). In this i... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Immunotherapeutic agents are increasingly becoming incorporated into clinical practice; however, there is still much to learn, including their optimal combinations, sequencing and usage. In this inter... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
The Phase III KEYNOTE-024 trial (NCT02142738) compared pembrolizumab monotherapy with standard platinum-based chemotherapy for previously untreated metastatic non-small cell lung cancer (NSCLC) with h... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
The European Lung Cancer Congress (ELCC) 2018, in Geneva, Switzerland, presented an array of exciting lung cancer trial updates. Speaking from the meeting, Marina Garassino, MD, of the Istituto Nazion... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Anti-angiogenic therapy has proven to be useful tool for the treatment of non-small cell lung cancer (NSCLC) in the frontline setting. Excitingly, there are now anti-angiogenic agents that can be used... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
The treatment of brain metastases in non-small cell lung cancer (NSCLC) is a challenge, as the majority of the drugs used to treat NSCLC exhibit low penetrance to the brain. Here, Marina Garassino, MD... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Canada Health | Cancer | Cancer & Oncology | Lung Cancer | Smokers